Last updated: September 18, 2024
Sponsor: University of Regina
Overall Status: Active - Recruiting
Phase
N/A
Condition
Sarcopenia
Treatment
Creatine Whey Protein
Whey Protein
Clinical Study ID
NCT06606717
825
Ages > 50 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Untrained (defined as those performing ≤ 1 resistance training session per week for ≥ 6 weeks prior to the start of the study)
Exclusion
Exclusion Criteria:
Taking creatine monohydrate within 30 days prior to the start of the study
Currently ingesting whey protein
Have pre-existing allergies to latex, fruit, dairy, nuts, seafood and mustard
Study Design
Total Participants: 36
Treatment Group(s): 2
Primary Treatment: Creatine Whey Protein
Phase:
Study Start date:
August 18, 2024
Estimated Completion Date:
July 31, 2025
Study Description
Connect with a study center
University of Regina
Regina, Saskatchewan S4S 0A2
CanadaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.